The shareholders in iCoat Medical AB (publ), corporate registration number 559172-8208 (the “Company”) are hereby convened […]
Press release 16 May 2022 iCoat Medical publishes Annual Report 2021. iCoat Medical today publishes its […]
Today, iCoat Medical welcomes Göran Lerenius as its General Counsel. As iCoat Medical is progressing its […]
On April 19th, Njurfonden published an interview with iCoat Medical’s Chief Medical Officer Alireza Biglarnia highlighting […]
Today, iCoat Medical announces that the European Commission has issued a positive decision on the company’s […]
Today, iCoat Medical welcomes Jacob Westman as its Head of Chemistry, Manufacturing and Controls on a […]
Today, iCoat Medical welcomes Mattias Springare as its incoming Chief Financial Officer and Head of Investor […]
The Swedish MPA conducted an on-site visit at Skåne University Hospital in December, the facilities were […]
The extra general meeting in iCoat Medical AB (publ), corp. reg. no 559172-8208 (the “Company”) was […]
December 3, 2021 iCoat Medical AB’s CEO, Peder Waern, and CMO, Alireza Biglarnia, will present at […]